Latest filing published 18 Jun 2025 for Maravai Lifesciences Holdings, INC., €167k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Benjamin James Daverman: trading record in brief
Benjamin James Daverman appears in our data through filings on Maravai Lifesciences Holdings, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 19 November 2021 to 16 June 2025.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 18 June 2025 with a share grant (€167k) in Maravai Lifesciences Holdings, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Benjamin James Daverman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 89,139 shares@ US$2.1644.7% of flowClass A Common StockSEC:0001823239-25-000089:0
- 20,645 shares@ US$10.78100.0% of flowClass A Common StockSEC:0001823239-24-000076:0
- 24,000 shares0Class A Common StockSEC:0001823239-23-000056:0
- 4,271 shares0Class A Common StockSEC:0000899243-21-045772:0
4 of 4 declarations
